A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML. [PDF]
Kropf PL +6 more
europepmc +1 more source
Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study. [PDF]
Zuo X +5 more
europepmc +1 more source
Synergistic rescue of temperature-sensitive p53 mutants by hypothermia and arsenic trioxide. [PDF]
Lu J, Chen L, Fatima Z, Huang J, Chen J.
europepmc +1 more source
Long-term Persistence of Dysplastic Features in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Arsenic Trioxide. [PDF]
Santinelli E +9 more
europepmc +1 more source
Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagy. [PDF]
Wang C +19 more
europepmc +1 more source
Paxillin promotes the invasion and migration of polyploid giant cancer cells with daughter cells after arsenic trioxide treatment by regulating the expression of cathepsin B/D. [PDF]
Wang J, Wang X, Li N, Liu K, Zhang S.
europepmc +1 more source
Astragalus polysaccharides inhibit arsenic trioxide-induced BMSCs damage through inhibition of Jnk and p38 signaling pathways. [PDF]
Wu W +20 more
europepmc +1 more source
Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach. [PDF]
Liu X +10 more
europepmc +1 more source

